Variants in this gene have previously been shown to associate with birthweight and the development of obesity and diabetes (Frayling et al., 2007) Their functional impact may be in modifying expression of the IRX3 and IRX5 genes, rather than FTO itself (Smemo et al., 2014). This evidence concerns the gene IRX5 and obesity disorder.